IP Library Granted Patent US 9,795,685
Granted Patent B2
US 9,795,685 · App. 15/342,772 · Granted Oct 24, 2017

Haptens of aripiprazole

Inventors: Ronghui Lin (Ambler, PA); Rhys Salter (Doylestown, PA); Thomas R. DeCory (Pittsford, NY); Eric Hryhorenko (Hilton, NY); Bart M. Remmerie (Ghent, BE); Banumathi Sankaran (Lexington, MA)
Assignee: JANSSEN PHARMACEUTICA NV
A61K47/4833A61K31/496A61K31/497A61K39/385A61K47/48238A61K47/48284C07D215/22C07D215/227C07D401/12C07D401/14A61K2039/6081
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,795,685
App. No.
15/342,772
Granted
Oct 24, 2017
Kind
B2
Abstract

The invention relates to compounds of Formula I, wherein R 1 , R 2 , and R 3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to conjugates of an aripiprazole hapten and a protein.

Claims (108)

1. A conjugate of the compound of Formula I and an immunogenic carrier:

wherein:

R 1 is H,

 CH 2 NH 2 , or CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H,

 NH 2 , or NHC(O)(CH 2 ) m CO 2 H;

R 3 is H; provided that either R 1 or R 2 must be H, and further provided that R 1 and R 2 may not be H simultaneously;

m is 1, 2, 3, 4, or 5; and

n is 1, 2, 3, 4, or 5.

2. The conjugate of claim 1 wherein:

R 1 is H,

 CH 2 NH 2 , or CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H,

 NH 2 , or NHC(O)(CH 2 ) m CO 2 H;

provided that either R 1 or R 2 must be H, and further provided that both R 1 and R 2 may not be H simultaneously;

R 3 is H;

m is 1, 2, 3 or 4; and

n is 1, 2, 3, 4, or 5.

3. The conjugate of claim 1 wherein:

R 1 is H,

 CH 2 NH 2 , or CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H,

 NH 2 , or NHC(O)(CH 2 ) m CO 2 H;

R 3 is H, provided that either R 1 or R 2 must be H, and further provided that both R 1 and R 2 may not be H simultaneously;

m is 1, 2, 3, 4, or 5; and

n is 1, 2, 3, 4, or 5.

4. The conjugate of claim 1 wherein:

R 1 is H,

 CH 2 NH 2 , CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H,

 NH 2 , NHC(O)(CH 2 ) m CO 2 H;

provided that either R 1 or R 2 must be H, and further provided that both R 1 and R 2 may not be H simultaneously;

R 3 is H;

m is 1, 2, or 3; and

n is 1, 2, or 3.

5. The conjugate of claim 1 , wherein the compound is

6. The conjugate of claim 5 , wherein the immunogenic carrier is a protein.

7. The conjugate of claim 6 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

8. The conjugate of claim 1 , wherein the compound is

9. The conjugate of claim 8 , wherein the immunogenic carrier is a protein.

10. The conjugate of claim 9 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

11. The conjugate of claim 1 , wherein the compound is

12. The conjugate of claim 11 , wherein the immunogenic carrier is a protein.

13. The conjugate of claim 12 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

14. The conjugate of claim 1 , wherein the compound is

wherein m is 2 or 3.

15. The conjugate of claim 14 , wherein the immunogenic carrier is a protein.

16. The conjugate of claim 15 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

17. The conjugate of claim 1 , wherein the compound is

18. The conjugate of claim 17 , wherein the immunogenic carrier is a protein.

19. The conjugate of claim 18 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

20. The conjugate of claim 1 , wherein the compound is

21. The conjugate of claim 20 , wherein the immunogenic carrier is a protein.

22. The conjugate of claim 21 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

23. A product made by the process of contacting a compound of Formula I with an immunogenic carrier:

wherein:

R 1 is H,

 CH 2 NH 2 , or CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H,

 NH 2 , or NHC(O)(CH 2 ) m CO 2 H;

R 3 is H; provided that either R 1 or R 2 must be H, and further provided that R 1 and R 2 may not be H simultaneously;

m is 1, 2, 3, 4, or 5; and

n is 1, 2, 3, 4, or 5.

24. The product of claim 23 , wherein:

R 1 is H,

 CH 2 NH 2 , or CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H,

 NH 2 , or NHC(O)(CH 2 ) m CO 2 H;

provided that either R 1 or R 2 must be H, and further provided that both R 1 and R 2 may not be H simultaneously;

R 3 is H;

m is 1, 2, 3 or 4; and

n is 1, 2, 3, 4, or 5.

25. The product of claim 23 , wherein:

R 1 is H,

 CH 2 NH 2 , or CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H,

 NH 2 , or NHC(O)(CH 2 ) m CO 2 H;

R 3 is H, provided that either R 1 or R 2 must be H, and further provided that both R 1 and R 2 may not be H simultaneously;

m is 1, 2, 3, 4, or 5; and

n is 1, 2, 3, 4, or 5.

26. The product of claim 23 , wherein:

R 1 is H,

 CH 2 NH 2 , CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H,

 NH 2 , NHC(O)(CH 2 ) m CO 2 H;

provided that either R 1 or R 2 must be H, and further provided that both R 1 and R 2 may not be H simultaneously;

R 3 is H;

m is 1, 2, or 3; and

n is 1, 2, or 3.

27. The product of claim 23 , wherein the compound is

28. The product of claim 27 , wherein the immunogenic carrier is a protein.

29. The product of claim 28 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

30. The product of claim 23 , wherein the compound is

31. The product of claim 30 , wherein the immunogenic carrier is a protein.

32. The product of claim 31 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

33. The product of claim 23 , wherein the compound is

34. The product of claim 33 , wherein the immunogenic carrier is a protein.

35. The product of claim 34 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

36. The product of claim 23 , wherein the compound is

wherein m is 2 or 3.

37. The product of claim 36 , wherein the immunogenic carrier is a protein.

38. The product of claim 37 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

39. The product of claim 23 , wherein the compound is

40. The product of claim 39 , wherein the immunogenic carrier is a protein.

41. The product of claim 40 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

42. The product of claim 23 , wherein the compound is

43. The product of claim 42 , wherein the immunogenic carrier is a protein.

44. The product of claim 43 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

Continuity (3)
Division 13970650 · Aug 20, 2013
Provisional Application 61691450 · Aug 21, 2012
Related Publication 20170072061A1 · Mar 16, 2017